A high-level overview of BeiGene, Ltd. (BGNE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment. BeiGene (BGNE) reported Q1 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, BeiGene's earnings per. View the BGNE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BeiGene Ltd real time. BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile. Stock analysis for BeiGene Ltd (BGNE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
BGNE earnings have grown at a % annualized rate, revenues have grown at a % annualized rate. The calculation is based on the 4-year Compound. Get Beigene Ltd (valerysolovei.ru) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Discover real-time BeiGene, Ltd. American Depositary Shares (BGNE) stock prices, quotes, historical data, news, and Insights for informed trading and. Beigene (BGNE) real time stock quotes, news, chart, key statistics and vital financial information with AInvest. View the latest BeiGene Ltd. ADR (BGNE) stock price, news, historical charts, analyst ratings and financial information from WSJ. BGNE - BeiGene Ltd ADR - Stock screener for investors and traders, financial visualizations. BeiGene Ltd is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients. View BeiGene (BGNE) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the Moomoo. Complete BeiGene Ltd. ADR stock information by Barron's. View real-time BGNE stock price and news, along with industry-best analysis. See charts, data and financials for BeiGene Ltd - ADR BGNE.
Get the latest updates on BeiGene, Ltd. American Depositary Shares (BGNE) pre market trades, share volumes, and more. Make informed investments with Nasdaq. BeiGene is a global, science-driven oncology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for. BeiGene Ltd. is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. Get the latest BeiGene Ltd. (BGNE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. BeiGene, Ltd. is a global biotechnology company engaged in discovering and developing oncology treatments for cancer patients worldwide. Get Beigene Ltd (BGNE.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. Get the latest Beigene Ltd (BGNE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading. Research BeiGene's (Nasdaq:BGNE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
BeiGene (BGNE) has a Smart Score of 8 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and. View BeiGene, Ltd BGNE investment & stock information. Get the latest BeiGene, Ltd BGNE detailed stock quotes, stock data, Real-Time ECN, charts. (NASDAQ: BGNE) Beigene stock price per share is $ today (as of Aug 23, ). The latest BeiGene stock prices, stock quotes, news, and BGNE history to help you invest and trade smarter.